Venmax Drugs and Pharmaceuticals Limited share price
BSE: VENMAX
Key numbers
- Market cap
- ₹ 21.7 Cr
- Current price
- ₹ 15.01
- 52-week high / low
- ₹ 31 / 13
- Stock P/E
- 62.5
- Book value
- ₹ 12.9
- Dividend yield
- 0.00%
- ROCE
- 3.0%
- ROE
- 3.4%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- -
- Profit growth (3 yrs)
- 2.8%
- 1-year return
- -43.1%
About Venmax Drugs and Pharmaceuticals Limited
Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API's in India. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 1 | 1 | 2 | 4 | 2 |
| Operating profit | 0 | 0 | -0 | 0 | 0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| EPS (₹) | 0.07 | 0.05 | 0.05 | 0.20 | 0.10 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.